title: Inhibition of defective adenylosuccinate lyase by HNE: a neurological disease that may be affected by oxidative stress.
abstract: Adenylosuccinate lyase is an enzyme of fumarase superfamily that participates in the purine biosynthetic pathway, catalysing the nonhydrolytic cleavage of succinyl groups from SAICA ribotide and adenylosuccinate. Enzyme defects are associated with a human inherited disease, which arises from single point mutations to the gene and results in mild to severe psychomotor retardation, epilepsy, muscle wasting, and autistic features. Adenylosuccinate lyase activity is lost to a different extent in the patients. Diminished levels of enzyme have been attributed to loss of catalytic activity, protein instability, or environmental factors. P100A/D422Y mutation represents a feasible model for studying the effect of cell milieu on the activity of the impaired enzyme. The defective enzyme is inhibited by micromolar concentrations of trans-4-hydroxy-2-nonenal (HNE), a major product of membrane peroxidation that has been found to accumulate in brain tissues of patients with neurodegenerative disorders. It is suggested that inactivation of defective adenylosuccinate lyase by HNE and other membrane peroxidation products may account, at least in part, for the impairment of neurological functions and recurrent worsening of the symptoms.
authors.affiliation: Department of Biochemical Sciences and Laboratory of Clinical Biochemistry, University of Rome La Sapienza, Rome, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Crifò
authors.forename: W
authors.initials: W
authors.lastname: Siems
authors.forename: S
authors.initials: S
authors.lastname: Soro
authors.forename: C
authors.initials: C
authors.lastname: Salerno
mesh_terms: D000264:Adenylosuccinate Lyase / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics*; D000447:Aldehydes / Q000378:metabolism / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D008958:Models, Molecular; D009154:Mutation; D020125:Mutation, Missense; D009422:Nervous System Diseases / Q000201:enzymology* / Q000378:metabolism; D018384:Oxidative Stress / Q000502:physiology*; D017354:Point Mutation; D011685:Purine Nucleotides / Q000096:biosynthesis
chemical_list: D000447:Aldehydes; D004791:Enzyme Inhibitors; D011685:Purine Nucleotides; D000264:Adenylosuccinate Lyase; C027576:4-hydroxy-2-nonenal